Literature DB >> 11115361

Dexamethasone enhances mallory body formation in drug-primed mouse liver.

Q X Yuan1, Y Nagao, B A French, Y J Wan, S W French.   

Abstract

In a clinical study in which patients with alcoholic hepatitis were treated with prednisone for 1 month, posttreatment liver biopsies showed diminished inflammation, but Mallory bodies were not diminished. This suggested that steroid treatment may reduce inflammation by inhibiting NFkappaB activation. Sparing of Mallory bodies suggests that NFkappaB activation may not be involved mechanistically in Mallory body formation. To test this idea, we induced Mallory body formation in drug-primed mice with or without dexamethasone treatment. As predicted, dexamethasone decreased NFkappaB activation; however, Mallory body formation was increased. Surprisingly, TNFalpha and iNOS, which normally increase as a result of NFkappaB activation, were upregulated by the dexamethasone treatment. It was concluded that NFkappaB activation is not involved in Mallory body formation. Despite this, induced increases in TNFalpha, iNOS, c-jun/API and c-myc expression indicate that oxidative stress is likely involved in Mallory body formation. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11115361     DOI: 10.1006/exmp.2000.2320

Source DB:  PubMed          Journal:  Exp Mol Pathol        ISSN: 0014-4800            Impact factor:   3.362


  8 in total

Review 1.  The role of innate immunity in the pathogenesis of preneoplasia in drug-induced chronic hepatitis based on a mouse model.

Authors:  S W French; F Bardag-Gorce; B A French; J Li; J Oliva
Journal:  Exp Mol Pathol       Date:  2011-07-28       Impact factor: 3.362

Review 2.  Alcohol, nutrition and liver cancer: role of Toll-like receptor signaling.

Authors:  Samuel W French; Joan Oliva; Barbara A French; Jun Li; Fawzia Bardag-Gorce
Journal:  World J Gastroenterol       Date:  2010-03-21       Impact factor: 5.742

3.  SAMe prevents the up regulation of toll-like receptor signaling in Mallory-Denk body forming hepatocytes.

Authors:  Fawzia Bardag-Gorce; Joan Oliva; Andrew Lin; Jun Li; Barbara A French; Samuel W French
Journal:  Exp Mol Pathol       Date:  2010-03-04       Impact factor: 3.362

4.  Mallory-Denk body pathogenesis revisited.

Authors:  Samuel W French; Fawzia Bardag-Gorce; Jun Li; Barbara A French; Joan Oliva
Journal:  World J Hepatol       Date:  2010-08-27

5.  SAMe prevents the induction of the immunoproteasome and preserves the 26S proteasome in the DDC-induced MDB mouse model.

Authors:  Fawzia Bardag-Gorce; Joan Oliva; Jun Li; Barbara A French; Samuel W French
Journal:  Exp Mol Pathol       Date:  2010-03-16       Impact factor: 3.362

6.  TLR3/4 signaling is mediated via the NFκB-CXCR4/7 pathway in human alcoholic hepatitis and non-alcoholic steatohepatitis which formed Mallory-Denk bodies.

Authors:  Hui Liu; Jun Li; Brittany Tillman; Timothy R Morgan; Barbara A French; Samuel W French
Journal:  Exp Mol Pathol       Date:  2014-07-02       Impact factor: 3.362

7.  A cell culture system for the induction of Mallory bodies: Mallory bodies and aggresomes represent different types of inclusion bodies.

Authors:  Kiyoko Hirano; Bruno Guhl; Jürgen Roth; Martin Ziak
Journal:  Histochem Cell Biol       Date:  2009-04-18       Impact factor: 4.304

8.  FAT10 knock out mice livers fail to develop Mallory-Denk bodies in the DDC mouse model.

Authors:  S W French; B A French; J Oliva; J Li; F Bardag-Gorce; B Tillman; A Canaan
Journal:  Exp Mol Pathol       Date:  2012-09-12       Impact factor: 3.362

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.